ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
7.11
-0.12 (-1.66%)
Jun 3, 2026, 3:40 PM EDT - Market open
ImmunityBio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, ImmunityBio stock has a consensus rating of "Strong Buy" and an average price target of $13. The average 1-year stock price forecast is 82.84% higher than the current stock price, while the lowest is $12 (+68.78%) and the highest is $15 (+110.97%).
Price Target: $13 (+82.84%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ImmunityBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 5 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +110.97% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +68.78% | Jun 1, 2026 |
| BTIG | BTIG | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +68.78% | May 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $9 | Buy | Maintains | $9 | +26.58% | Dec 12, 2025 |
Financial Forecast
Revenue This Year
222.38M
from 113.29M
Increased by 96.30%
Revenue Next Year
452.02M
from 222.38M
Increased by 103.26%
EPS This Year
-0.85
from -0.38
EPS Next Year
-0.16
from -0.85
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 251.8M | ||
| Avg | 222.4M | ||
| Low | 198.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 122.3% | ||
| Avg | 96.3% | ||
| Low | 75.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.81 | ||
| Avg | -0.85 | ||
| Low | -0.88 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.